Superworth

NU Skin Enterprises PE ratio NUS

Share price divided by earnings per share over the last twelve months, since 2011.

Today, Oct 23, 2026
n/m
losses over the last year
Last meaningful
5.0×
Aug 2026
10-year median
19.2×
10-year range
4.6× to 76.8×
Peer median
21.4×

NU Skin Enterprises has no meaningful PE ratio today: it lost $4.47 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Aug 2026, at 5.0×.

On the days it had one over the last ten years, its median was 19.2×, from 4.6× in Jul 2026 to 76.8× in Mar 2024.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far5.0×4.6×6.5×
2025n/m a value too high to mean anything
202468.9×14.7×76.8×
202316.5×13.0×60.6×
202257.8×11.3×57.8×
202111.5×8.8×20.3×
202018.4×6.3×20.9×
201919.6×17.1×29.7×
201821.3×20.3×33.3×
201724.9×18.4×25.5×
201619.5×12.1×37.0×
201515.8×9.4×19.7×
201410.6×7.9×28.2×
201328.0×11.5×29.6×
201210.7×10.4×25.6×
201122.2×17.6×25.5×

Against its peers

Companies in Healthcare nearest NU Skin Enterprises' size, closest first, today.

CompanyPE ratio
NUSNU Skin Enterprisesn/m
UTMDUtah Medical Products22.6×
ELMDElectromed20.1×
NATRNatures Sunshine Products12.0×
PLXProtalix BioTherapeutics11.1×
PDEXPro DEX15.1×
INFUInfuSystem34.0×
VMDViemed Healthcare27.2×
EMBCEmbecta4.6×
ARVNArvinas45.6×
NRCNRC Health87.7×
Peer median21.4×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on NU Skin Enterprises

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.